Pancreatic adverse events of immune checkpoint inhibitors therapy for solid cancer patients: a systematic review and meta-analysis

OBJECTIVE: This review aims to determine the incidence and risk of pancreatic adverse events (AEs) associated with immune checkpoint inhibitors (ICIs) therapy for solid tumors. METHODS: We conducted a comprehensive systematic literature search in PubMed, Embase, and Cochrane Library up to March 15,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zhe, Zhang, Weike, Pang, Longbin, Zeng, Liangjie, Liu, Surui, Liu, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289552/
https://www.ncbi.nlm.nih.gov/pubmed/37359551
http://dx.doi.org/10.3389/fimmu.2023.1166299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289552/
https://www.ncbi.nlm.nih.gov/pubmed/37359551
http://dx.doi.org/10.3389/fimmu.2023.1166299

Ejemplares similares